Global Crosscarmellose Sodium Market Overview
The Crosscarmellose Sodium market is expected to grow steadily between 2026 and 2036, driven by rising demand for pharmaceutical excipients, increasing production of tablets and capsules, and advancements in drug formulation technologies. The compound is widely used as a superdisintegrant in oral solid dosage forms, enhancing drug bioavailability and patient compliance. Growth is supported by expanding pharmaceutical manufacturing in emerging economies and rising investments in healthcare infrastructure.
Segments Analysis
By Type
· Tablet – Widely used in solid oral dosage forms to improve disintegration.
· Capsule – Enhances dissolution and absorption in capsule formulations.
· Granules – Used in multi-particulate drug delivery systems.
· Others – Customized excipient applications in specialty formulations.
By Application
· Filler-binders – Provides structural integrity to tablets.
· Extra-granular Superdisintegrant – Ensures rapid disintegration and dissolution.
· Controlled-release formulations – Applied in modified drug delivery systems.
· Others – Nutraceuticals and veterinary medicines.
Regional Analysis
· North America: Strong pharmaceutical industry, high adoption of advanced excipients.
· Europe: Regulatory support for excipient innovation, growing generic drug production.
· Asia-Pacific: Rapid expansion of pharmaceutical manufacturing, rising healthcare demand.
· South America: Emerging pharmaceutical sector, increasing investments in healthcare.
· Middle East & Africa: Gradual growth, limited but expanding pharmaceutical infrastructure.
Key Players
· Parchem Fine & Specialty Chemicals
· DFE Pharma
· Prachin Chemical
· Abhishek Organics
· JRS Pharma
· Foshan City Chemical
· Hebei Tianwei
· Hunan Sentai Biotechnology
· Anllan Chemical
· Roquette Frères
· Ashland Global
· Avantor Inc
Porter’s Five Forces
· Threat of New Entrants: Moderate, due to regulatory requirements and capital investment.
· Bargaining Power of Suppliers: Low, as raw materials are widely available.
· Bargaining Power of Buyers: High, with demand for cost-effective excipients.
· Threat of Substitutes: Moderate, with alternative disintegrants available.
· Industry Rivalry: Intense, driven by global competition and innovation.
SWOT Analysis
· Strengths: High efficiency as a superdisintegrant, wide pharmaceutical adoption.
· Weaknesses: Dependence on pharmaceutical industry growth, price sensitivity.
· Opportunities: Expansion in nutraceuticals and emerging markets.
· Threats: Competition from alternative excipients, regulatory challenges.
Trend Analysis
· Rising demand for orally disintegrating tablets (ODTs).
· Increasing focus on patient-centric drug delivery systems.
· Growth in generic drug manufacturing.
· Expansion of nutraceutical applications.
Drivers
· Rising global pharmaceutical production.
· Growing demand for fast-dissolving drug formulations.
· Expansion of healthcare infrastructure in emerging economies.
Challenges
· Stringent regulatory compliance requirements.
· Price competition among excipient manufacturers.
· Limited awareness in developing regions.
Value Chain Analysis
· Raw Material Procurement → Chemical Processing → Excipients Manufacturing → Distribution → Pharmaceutical Formulation → End-Use Applications
Quick Recommendations for Stakeholders
· Investors: Focus on companies with strong excipient portfolios and global distribution networks.
· Pharma Companies: Leverage crosscarmellose sodium in ODTs and fast-release formulations.
· Researchers: Explore new applications in nutraceuticals and controlled-release systems.
· Regulators: Support innovation while ensuring safety and compliance.
· Suppliers: Strengthen partnerships with pharmaceutical manufacturers to ensure consistent demand.
1. Market Overview of Crosscarmellose Sodium
1.1 Crosscarmellose Sodium Market Overview
1.1.1 Crosscarmellose Sodium Product Scope
1.1.2 Market Status and Outlook
1.2 Crosscarmellose Sodium Market Size by Regions:
1.3 Crosscarmellose Sodium Historic Market Size by Regions
1.4 Crosscarmellose Sodium Forecasted Market Size by Regions
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Crosscarmellose Sodium Sales Market by Type
2.1 Global Crosscarmellose Sodium Historic Market Size by Type
2.2 Global Crosscarmellose Sodium Forecasted Market Size by Type
2.3 Tablet
2.4 Capsule
2.5 Others
3. Covid-19 Impact Crosscarmellose Sodium Sales Market by Application
3.1 Global Crosscarmellose Sodium Historic Market Size by Application
3.2 Global Crosscarmellose Sodium Forecasted Market Size by Application
3.3 Filler-binders
3.4 Extra-granular Superdisintegrant
3.5 Others
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Crosscarmellose Sodium Production Capacity Market Share by Manufacturers
4.2 Global Crosscarmellose Sodium Revenue Market Share by Manufacturers
4.3 Global Crosscarmellose Sodium Average Price by Manufacturers
5. Company Profiles and Key Figures in Crosscarmellose Sodium Business
5.1 Parchem fine & specialty chemicals
5.1.1 Parchem fine & specialty chemicals Company Profile
5.1.2 Parchem fine & specialty chemicals Crosscarmellose Sodium Product Specification
5.1.3 Parchem fine & specialty chemicals Crosscarmellose Sodium Production Capacity, Revenue, Price and Gross Margin
5.2 DFE pharma
5.2.1 DFE pharma Company Profile
5.2.2 DFE pharma Crosscarmellose Sodium Product Specification
5.2.3 DFE pharma Crosscarmellose Sodium Production Capacity, Revenue, Price and Gross Margin
5.3 Prachin Chemical
5.3.1 Prachin Chemical Company Profile
5.3.2 Prachin Chemical Crosscarmellose Sodium Product Specification
5.3.3 Prachin Chemical Crosscarmellose Sodium Production Capacity, Revenue, Price and Gross Margin
5.4 Abhishek Organics
5.4.1 Abhishek Organics Company Profile
5.4.2 Abhishek Organics Crosscarmellose Sodium Product Specification
5.4.3 Abhishek Organics Crosscarmellose Sodium Production Capacity, Revenue, Price and Gross Margin
5.5 Wealthy
5.5.1 Wealthy Company Profile
5.5.2 Wealthy Crosscarmellose Sodium Product Specification
5.5.3 Wealthy Crosscarmellose Sodium Production Capacity, Revenue, Price and Gross Margin
5.6 CELLULOSE PHARMA CHEM
5.6.1 CELLULOSE PHARMA CHEM Company Profile
5.6.2 CELLULOSE PHARMA CHEM Crosscarmellose Sodium Product Specification
5.6.3 CELLULOSE PHARMA CHEM Crosscarmellose Sodium Production Capacity, Revenue, Price and Gross Margin
5.7 MARUTI CHEMICALS
5.7.1 MARUTI CHEMICALS Company Profile
5.7.2 MARUTI CHEMICALS Crosscarmellose Sodium Product Specification
5.7.3 MARUTI CHEMICALS Crosscarmellose Sodium Production Capacity, Revenue, Price and Gross Margin
5.8 JRS PHARMA
5.8.1 JRS PHARMA Company Profile
5.8.2 JRS PHARMA Crosscarmellose Sodium Product Specification
5.8.3 JRS PHARMA Crosscarmellose Sodium Production Capacity, Revenue, Price and Gross Margin
5.9 Foshan City Chemical
5.9.1 Foshan City Chemical Company Profile
5.9.2 Foshan City Chemical Crosscarmellose Sodium Product Specification
5.9.3 Foshan City Chemical Crosscarmellose Sodium Production Capacity, Revenue, Price and Gross Margin
5.10 Ever Bright
5.10.1 Ever Bright Company Profile
5.10.2 Ever Bright Crosscarmellose Sodium Product Specification
5.10.3 Ever Bright Crosscarmellose Sodium Production Capacity, Revenue, Price and Gross Margin
5.11 Hebei Tianwei
5.11.1 Hebei Tianwei Company Profile
5.11.2 Hebei Tianwei Crosscarmellose Sodium Product Specification
5.11.3 Hebei Tianwei Crosscarmellose Sodium Production Capacity, Revenue, Price and Gross Margin
5.12 Hunan Sentai Biotechnology
5.12.1 Hunan Sentai Biotechnology Company Profile
5.12.2 Hunan Sentai Biotechnology Crosscarmellose Sodium Product Specification
5.12.3 Hunan Sentai Biotechnology Crosscarmellose Sodium Production Capacity, Revenue, Price and Gross Margin
5.13 Anllan Chemical
5.13.1 Anllan Chemical Company Profile
5.13.2 Anllan Chemical Crosscarmellose Sodium Product Specification
5.13.3 Anllan Chemical Crosscarmellose Sodium Production Capacity, Revenue, Price and Gross Margin
6. North America
6.1 North America Crosscarmellose Sodium Market Size
6.2 North America Crosscarmellose Sodium Key Players in North America
6.3 North America Crosscarmellose Sodium Market Size by Type
6.4 North America Crosscarmellose Sodium Market Size by Application
7. East Asia
7.1 East Asia Crosscarmellose Sodium Market Size
7.2 East Asia Crosscarmellose Sodium Key Players in North America
7.3 East Asia Crosscarmellose Sodium Market Size by Type
7.4 East Asia Crosscarmellose Sodium Market Size by Application
8. Europe
8.1 Europe Crosscarmellose Sodium Market Size
8.2 Europe Crosscarmellose Sodium Key Players in North America
8.3 Europe Crosscarmellose Sodium Market Size by Type
8.4 Europe Crosscarmellose Sodium Market Size by Application
9. South Asia
9.1 South Asia Crosscarmellose Sodium Market Size
9.2 South Asia Crosscarmellose Sodium Key Players in North America
9.3 South Asia Crosscarmellose Sodium Market Size by Type
9.4 South Asia Crosscarmellose Sodium Market Size by Application
10. Southeast Asia
10.1 Southeast Asia Crosscarmellose Sodium Market Size
10.2 Southeast Asia Crosscarmellose Sodium Key Players in North America
10.3 Southeast Asia Crosscarmellose Sodium Market Size by Type
10.4 Southeast Asia Crosscarmellose Sodium Market Size by Application
11. Middle East
11.1 Middle East Crosscarmellose Sodium Market Size
11.2 Middle East Crosscarmellose Sodium Key Players in North America
11.3 Middle East Crosscarmellose Sodium Market Size by Type
11.4 Middle East Crosscarmellose Sodium Market Size by Application
12. Africa
12.1 Africa Crosscarmellose Sodium Market Size
12.2 Africa Crosscarmellose Sodium Key Players in North America
12.3 Africa Crosscarmellose Sodium Market Size by Type
12.4 Africa Crosscarmellose Sodium Market Size by Application
13. Oceania
13.1 Oceania Crosscarmellose Sodium Market Size
13.2 Oceania Crosscarmellose Sodium Key Players in North America
13.3 Oceania Crosscarmellose Sodium Market Size by Type
13.4 Oceania Crosscarmellose Sodium Market Size by Application
14. South America
14.1 South America Crosscarmellose Sodium Market Size
14.2 South America Crosscarmellose Sodium Key Players in North America
14.3 South America Crosscarmellose Sodium Market Size by Type
14.4 South America Crosscarmellose Sodium Market Size by Application
15. Rest of the World
15.1 Rest of the World Crosscarmellose Sodium Market Size
15.2 Rest of the World Crosscarmellose Sodium Key Players in North America
15.3 Rest of the World Crosscarmellose Sodium Market Size by Type
15.4 Rest of the World Crosscarmellose Sodium Market Size by Application
16 Crosscarmellose Sodium Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Segments Analysis
By Type
· Tablet – Widely used in solid oral dosage forms to improve disintegration.
· Capsule – Enhances dissolution and absorption in capsule formulations.
· Granules – Used in multi-particulate drug delivery systems.
· Others – Customized excipient applications in specialty formulations.
By Application
· Filler-binders – Provides structural integrity to tablets.
· Extra-granular Superdisintegrant – Ensures rapid disintegration and dissolution.
· Controlled-release formulations – Applied in modified drug delivery systems.
· Others – Nutraceuticals and veterinary medicines.
Regional Analysis
· North America: Strong pharmaceutical industry, high adoption of advanced excipients.
· Europe: Regulatory support for excipient innovation, growing generic drug production.
· Asia-Pacific: Rapid expansion of pharmaceutical manufacturing, rising healthcare demand.
· South America: Emerging pharmaceutical sector, increasing investments in healthcare.
· Middle East & Africa: Gradual growth, limited but expanding pharmaceutical infrastructure.
Key Players
· Parchem Fine & Specialty Chemicals
· DFE Pharma
· Prachin Chemical
· Abhishek Organics
· JRS Pharma
· Foshan City Chemical
· Hebei Tianwei
· Hunan Sentai Biotechnology
· Anllan Chemical
· Roquette Frères
· Ashland Global
· Avantor Inc
